Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO): 20 pipeline candidates · ~4 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
4.1 months
D/E 0.57 · 0% dilution
Lead: Approved
20 candidates
N/A
2 buys · 0 sells (180d)
A transparent, data-derived signal for Organogenesis Holdings Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$301.1M
Cash
$92.1M
Quarterly Burn
$106.1M
Runway
4.1 mo
Revenue
$37.2M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (20 candidates)
Showing 10 of 20 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
119
Total value held
$111.6M
| Holder | Shares | Value |
|---|---|---|
| morgan stanley | 11,616,795 | $27.5M |
| vanguard capital management llc | 5,801,632 | $13.7M |
| blackrock, inc. | 4,899,751 | $11.6M |
| dimensional fund advisors lp | 2,891,006 | $6.9M |
| d. e. shaw & co., inc. | 2,297,974 | $5.4M |
| geode capital management, llc | 1,783,964 | $4.2M |
| deutsche bank ag\ | 1,705,681 | $4.0M |
| state street corp | 1,525,108 | $3.6M |
| vanguard portfolio management llc | 1,449,092 | $3.4M |
| renaissance technologies llc | 1,068,538 | $2.5M |
Showing top 10 of 119 institutional holders of Organogenesis Holdings Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Organogenesis Holdings Inc.'s pipeline?
Organogenesis Holdings Inc. (ORGO) has 20 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Organogenesis Holdings Inc.'s lead drug candidate?
Organogenesis Holdings Inc.'s most advanced tracked candidate is apligraf (Approved) for General, Plastic Surgery.
What is Organogenesis Holdings Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Organogenesis Holdings Inc. has approximately 4.1 months of cash runway.
What is Organogenesis Holdings Inc.'s market capitalization?
Organogenesis Holdings Inc.'s market capitalization is approximately $301.1M.
Who is the CEO of Organogenesis Holdings Inc.?
Mr. Gary S. Gillheeney Sr. is the chief executive officer of Organogenesis Holdings Inc. (ORGO).
Get the full picture on Organogenesis Holdings Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.